Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway.

Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway. Minerva Endocrinol. 2020 Feb 18;: Authors: Cheng S, Li L, Song C, Jin H, Ma S, Kang P PMID: 32077673 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32077673?dopt=Abstract

Source: Minerva Endocrinologica - February 22, 2020 Category: Endocrinology Tags: Minerva Endocrinol Source Type: research

More News: Diabetes | Endocrinology | Januvia